949 related articles for article (PubMed ID: 32173110)
21. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
22. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
23. Chloroquine for COVID-19 Infection.
Moore N
Drug Saf; 2020 May; 43(5):393-394. PubMed ID: 32266694
[No Abstract] [Full Text] [Related]
24. Update on treatment of COVID-19: ongoing studies between promising and disappointing results.
Esposito S; Noviello S; Pagliano P
Infez Med; 2020 Ahead of print Jun 1; 28(2):198-211. PubMed ID: 32335561
[TBL] [Abstract][Full Text] [Related]
25. Race to find COVID-19 treatments accelerates.
Kupferschmidt K; Cohen J
Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
[No Abstract] [Full Text] [Related]
26. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
Sahraei Z; Shabani M; Shokouhi S; Saffaei A
Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
[No Abstract] [Full Text] [Related]
27. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
28. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
[TBL] [Abstract][Full Text] [Related]
29. Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19.
Fidahic M; Nujic D; Runjic R; Civljak M; Markotic F; Lovric Makaric Z; Puljak L
BMC Med Res Methodol; 2020 Jun; 20(1):161. PubMed ID: 32571302
[TBL] [Abstract][Full Text] [Related]
30. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
Ibáñez S; Martínez O; Valenzuela F; Silva F; Valenzuela O
Clin Rheumatol; 2020 Aug; 39(8):2461-2465. PubMed ID: 32495226
[TBL] [Abstract][Full Text] [Related]
31. Chloroquine paradox may cause more damage than help fight COVID-19.
Sharma A
Microbes Infect; 2020; 22(4-5):154-156. PubMed ID: 32305500
[TBL] [Abstract][Full Text] [Related]
32. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)].
Gao Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Apr; 32(2):119-122. PubMed ID: 32458599
[TBL] [Abstract][Full Text] [Related]
34. Emerging prophylaxis strategies against COVID-19.
Agrawal S; Goel AD; Gupta N
Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231348
[TBL] [Abstract][Full Text] [Related]
35. Role for antimalarials in the management of COVID-19.
Schrezenmeier EV; Burmester GR; Eckardt KU; Dörner T
Curr Opin Rheumatol; 2020 Sep; 32(5):449-457. PubMed ID: 32675717
[TBL] [Abstract][Full Text] [Related]
36. [Chloroquine as a possible treatment for COVID-19].
Coumou J; de Vries PJ
Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999
[TBL] [Abstract][Full Text] [Related]
37. Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.
Millán-Oñate J; Millan W; Mendoza LA; Sánchez CG; Fernandez-Suarez H; Bonilla-Aldana DK; Rodríguez-Morales AJ
Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):16. PubMed ID: 32331519
[TBL] [Abstract][Full Text] [Related]
38. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
D'Acquarica I; Agranat I
Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
[No Abstract] [Full Text] [Related]
39. Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
Schluenz LA; Ramos-Otero GP; Nawarskas JJ
Cardiol Rev; 2020; 28(5):266-271. PubMed ID: 32769401
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
Trials; 2020 May; 21(1):422. PubMed ID: 32448345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
